SCHEMBL3936693

SCHEMBL3936693

CN1CCC(NC(=O)c2cc(Cl)c(N)cc2F)C1

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 3/20 0.51
DRD4 P21917 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3552993 1.00 HTR4 (0.51) HTR4DRD4
SCHEMBL3540611 0.93 HTR4 (0.55) HTR4DRD4
SCHEMBL3936908 0.89 USP30 (0.47)
SCHEMBL3540628 0.89 USP30 (0.47)
SCHEMBL19175394 0.84 RIPK2 (0.44)
SCHEMBL3538922 0.84 HTR4 (0.47) HTR4DRD4
SCHEMBL3942580 0.84 HTR4 (0.47) HTR4DRD4
SCHEMBL11557104 0.84 HTR4 (0.72) HTR4DRD4
SCHEMBL3542078 0.82 HTR4 (0.72) HTR4DRD4
SCHEMBL1781337 0.81 ACKR3 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046793-A2 FUSED PYRIMIDO COMPOUNDS AstraZeneca AB (SE) 2009-04-15 EP disclosed
WO-2008040951-A1 COMPOUNDS ASTRAZENECA AB (SE) 2008-04-10 WO disclosed
WO-2008003958-A2 FUSED PYRIMIDO COMPOUNDS ASTRAZENECA AB (SE) 2008-01-10 WO disclosed